(RTTNews) - Amneal Pharmaceuticals (AMRX) announced it has received FDA approval of its New Drug Application for Pyridostigmine Bromide Extended-Release Tablets USP 105 mg. PB ER 105 mg tablets are a ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (AMRX) (“Amneal” or the “Company”), a global pharmaceutical company based in the U.S., today announced that it has received U.S. Food ...
Action And Clinical Pharmacology: Pyridostigmine is a cholinergic agent which acts primarily by the inhibition of cholinesterase. It enhances cholinergic action by facilitating the transmission of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback